[肺结核患者化疗副作用的消除]
[The elimination of chemotherapy side effects in pulmonary tuberculosis patients].
作者信息
Bal'tseva L B, Mel'nik G V, Man'ko V P
出版信息
Vrach Delo. 1990 Apr(4):71-3.
PMID:2275176
Abstract
Neurotoxic side-effects of tuberculosis chemotherapy occurred in 14.9% of patients with tuberculosis treated prophylactically with intramuscular pyridoxine infusions. Use of small doses of nootropil (piracetam) allowed to control the side-effects (headache and vertigo, sleep disorders, irritation, memory disorders) and to continue treatment with isoniazide, one of the most potent tuberculostatic agents.
摘要
接受肌肉注射吡哆醇预防性治疗的肺结核患者中，有14.9%出现了结核化疗的神经毒性副作用。使用小剂量的脑复康（吡拉西坦）能够控制这些副作用（头痛、眩晕、睡眠障碍、易怒、记忆障碍），并能够继续使用异烟肼进行治疗，异烟肼是最有效的抗结核药物之一。
相似文献
1
[The elimination of chemotherapy side effects in pulmonary tuberculosis patients].[肺结核患者化疗副作用的消除]
Vrach Delo. 1990 Apr(4):71-3.
2
[Adverse neurotoxic reactions of chemotherapy for tuberculosis and their treatment].[抗结核化疗的神经毒性不良反应及其治疗]
Probl Tuberk Bolezn Legk. 2006(9):45-8.
3
4
5
[Chemotherapy in combination with the rapid intravenous administration of isoniazid in pulmonary tuberculosis].[肺结核中化疗联合异烟肼快速静脉给药]
Probl Tuberk. 1982 Dec(12):45-8.
6
[Controversy over tuberculosis therapy in HIV infected patients. Isoniazide therapy--brief chemotherapy].
Fortschr Med. 1995 Dec 20;113(35-36):14-5.
7
[Intensive chemotherapy regimens in pulmonary tuberculosis with concomitant diabetes mellitus].[合并糖尿病的肺结核的强化化疗方案]
Vrach Delo. 1990 Sep(9):87-8.
8
9
[Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].[耐异烟肼或耐利福平结核病的特征及治疗结果]
Kekkaku. 2003 Oct;78(10):611-7.
10
[The use of fenazid in patients with pulmonary tuberculosis with poor isoniazid tolerance].[对异烟肼耐受性差的肺结核患者使用非那齐德的情况]
Probl Tuberk Bolezn Legk. 2003(7):34-7.
引用本文的文献
1
The effects of isoniazid on hippocampal NMDA receptors: protective role of erdosteine.
Mol Cell Biochem. 2005 Sep;277(1-2):131-5. doi: 10.1007/s11010-005-5778-x.
Zotero 插件